✦ LIBER ✦

Evaluation of the transport, in vitro metabolism and pharmacokinetics of Salvinorin A, a potent hallucinogen

✍ Scribed by Zeynep S. Teksin; Insong J. Lee; Noble N. Nemieboka; Ahmed A. Othman; Vijay V. Upreti; Hazem E. Hassan; Shariq S. Syed; Thomas E. Prisinzano; Natalie D. Eddington

Book ID: 116438152
Publisher: Elsevier Science
Year: 2009
Tongue: French
Weight: 368 KB
Volume: 72
Category: Article
ISSN: 0939-6411
DOI: 10.1016/j.ejpb.2009.01.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of the potent hallucino

Pharmacokinetics of the potent hallucinogen, salvinorin A in primates parallels the rapid onset and short duration of effects in humans

✍ Jacob M. Hooker; Youwen Xu; Wynne Schiffer; Colleen Shea; Pauline Carter; Joanna 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 353 KB

Kappa opioid mediation of cannabinoid ef

Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents

✍ D. Matthew Walentiny; Robert E. Vann; Jonathan A. Warner; Lindsey S. King; Herbe 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 241 KB

Preclinical pharmacokinetics and in vitr

Preclinical pharmacokinetics and in vitro metabolism of BMS-690514, a potent inhibitor of EGFR and VEGFR2

✍ Punit Marathe; Yuwei Tang; Bogdan Sleczka; David Rodrigues; Ashvinikumar Gavai; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 409 KB

BMS-690514, a potent inhibitor of human epidermal growth factor receptor (HER) 1 (EGFR), 2, and 4, and vascular endothelial growth factor receptors (VEGFR) 1-3, is currently under investigation as an oral agent for the treatment of solid tumors. In vitro and in vivo studies were conducted to charact

Human psychopharmacology and dose-effect

Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum

✍ Matthew W. Johnson; Katherine A. MacLean; Chad J. Reissig; Thomas E. Prisinzano; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 405 KB

Fluvoxamine is a Potent Inhibitor of the

Fluvoxamine is a Potent Inhibitor of the Metabolism of Caffeinein vitro

✍ Rasmussen, Birgitte Buur ;Nielsen, Torben Leo ;Brøsen, Kim 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 604 KB

In Vitro and In Vivo Metabolism and Phar

In Vitro and In Vivo Metabolism and Pharmacokinetics of BMS-562086, a Potent and Orally Bioavailable Corticotropin-Releasing Factor-1 Receptor Antagonist

✍ Zhou, L.; Dockens, R. C.; Liu-Kreyche, P.; Grossman, S. J.; Iyer, R. A. 📂 Article 📅 2012 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 466 KB